-
Views
-
Cite
Cite
A Takasaki, T Kurita, J Masuda, K Dohi, K Hoshino, T Tanigawa, Y Saito, T Kitamura, H Kakimoto, M Setsuda, K Makino, T Ichikawa, M Ito, P1717
The clinical impact of intra-aortic balloon pumping for acute coronary syndrome from Mie ACS registry, European Heart Journal, Volume 40, Issue Supplement_1, October 2019, ehz748.0472, https://doi.org/10.1093/eurheartj/ehz748.0472 - Share Icon Share
Abstract
Intra-Aortic Balloon Pumping (IABP) was widespread used in cases of Acute Coronary Syndrome (ACS) at daily clinical situation in Japan, even though the efficacy of IABP in AMI patients with cardiogenic shock was not proved. The aim of this study was to investigate the efficacy of IABP use in ACS patients in Japan.
We investigated 2-year all-cause-mortality of 2,660 enrolled ACS patients including 358 patients with IABP and 2,302 patients without IABP from Mie ACS registry.
We compared a 1:1 propensity score-matched cohort of 426 ACS patients with or without IABP (n=213, respectively). 2-year mortality was significantly higher in patients with IABP than without IABP (p=0.02, Figure A). In addition, IABP usage was independent predictor of mortality with hazard ratio of 1.6 by multivariate analysis. However, 2-year mortality was not statistically different between 2 groups only when analyzed patients with shock (p=0.60, Figure B).

Figure 1
IABP was not commonly recommended in ACS patients. However, IABP was might as well used in some situation especially in shock.